88 related articles for article (PubMed ID: 17142142)
1. Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus.
Hui-Bing H; Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K; Kimura H
Metabolism; 2006 Dec; 55(12):1670-3. PubMed ID: 17142142
[TBL] [Abstract][Full Text] [Related]
2. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
[TBL] [Abstract][Full Text] [Related]
3. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
[TBL] [Abstract][Full Text] [Related]
4. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.
Schäffler A; Büchler C; Müller-Ladner U; Herfarth H; Ehling A; Paul G; Schölmerich J; Zietz B
Horm Metab Res; 2004 Oct; 36(10):702-7. PubMed ID: 15523596
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
6. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella NA
Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
[TBL] [Abstract][Full Text] [Related]
7. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
8. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
Al-Sari IE; Al-Quobaili FA; Kabalan YM
Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
[TBL] [Abstract][Full Text] [Related]
9. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.
Habib SS
Saudi Med J; 2012 May; 33(5):495-9. PubMed ID: 22588809
[TBL] [Abstract][Full Text] [Related]
10. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus.
Kuzmicki M; Telejko B; Szamatowicz J; Zonenberg A; Nikolajuk A; Kretowski A; Gorska M
Gynecol Endocrinol; 2009 Apr; 25(4):258-63. PubMed ID: 19408175
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin, resistin and subclinical inflammation--the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity.
Harsch IA; Bergmann T; Koebnick C; Wiedmann R; Ruderich F; Hahn EG; Konturek PC
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():65-76. PubMed ID: 17443028
[TBL] [Abstract][Full Text] [Related]
12. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
14. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes.
Kadoglou NP; Perrea D; Iliadis F; Angelopoulou N; Liapis C; Alevizos M
Diabetes Care; 2007 Mar; 30(3):719-21. PubMed ID: 17327348
[No Abstract] [Full Text] [Related]
15. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study.
Herder C; Peltonen M; Koenig W; Kräft I; Müller-Scholze S; Martin S; Lakka T; Ilanne-Parikka P; Eriksson JG; Hämäläinen H; Keinänen-Kiukaanniemi S; Valle TT; Uusitupa M; Lindström J; Kolb H; Tuomilehto J
Diabetes; 2006 Aug; 55(8):2340-6. PubMed ID: 16873699
[TBL] [Abstract][Full Text] [Related]
17. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
18. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus.
Tesauro M; Rizza S; Iantorno M; Campia U; Cardillo C; Lauro D; Leo R; Turriziani M; Cocciolillo GC; Fusco A; Panza JA; Scuteri A; Federici M; Lauro R; Quon MJ
Metabolism; 2007 Mar; 56(3):413-9. PubMed ID: 17292732
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between resistin and the peripheral neuropathy in type 2 diabetes].
Wang XH; Wang DQ; Chen SH; Zhang L; Ni YH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1755-7. PubMed ID: 17919381
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
